US4448632038 - Common Stock
Humanigen stock is falling hard on Friday as investors in HGEN sell shares after the company announced a bankruptcy filing.
The RATinG (Risk Adapted Therapy in Acute GvHD) is the first trial to explore granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralization for...
Biogen (BIIB) layoffs are on the way as the company seeks further profits with its upcoming Alzheimer's disease drug launch.
Bellerophon Therapeutics (BLPH) stock is losing value on Tuesday after the clinical-stage therapeutics company was sent a delisting notice.
Humanigen (HGEN) stock is falling hard on Tuesday after the company warned investors it can't keep listing requirements.
It's time for another dive into the biggest pre-market stock movers as we check out the most recent news for Tuesday morning!
Nano-cap biotech Humanigen (HGEN) fell ~70% pre-market Tuesday after announcing that Nasdaq has decided to delist its shares from the exchange and the company is evaluating all...
Of the 14 participants enrolled and treated with lenzilumab plus azacitidine, ten are evaluable with three to eighteen months of...
CMML is an aggressive, poorly understood cancer; approximately 20% of patients survive three years from diagnosisEleven subjects dosed with lenzilumab...
We're starting off another day of trading with a breakdown of the biggest pre-market stock movers for trader need to kno about Wednesday!
San Diego, CA -- (SBWIRE) -- 12/15/2022 -- An investigation was announced for current long-term investors in shares of Humanigen, Inc. (NASDAQ: HGEN) concerning potential breaches of fiduciary duties by certain directors of Humanigen, Inc.
Short Hills, New Jersey--(Newsfile Corp. - November 14, 2022) - Humanigen, Inc. (Nasdaq: HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused...
Short Hills, New Jersey--(Newsfile Corp. - November 10, 2022) - Humanigen, Inc. (Nasdaq: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical company focused...